Search

everythinglearnresearchcommunity

for

Search:↓

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

PRP is more effective than minoxidil and placebo for treating hair loss.

A genetic defect in vitamin D receptors causes severe rickets and hair loss in children, but some heal as they age.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Blocking neurosteroid production can lead to more seizures and faster epilepsy onset in rats.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Disrupted stem cell signals in hairpoor mice cause hair loss.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Anti-androgens can help reduce the effects of male hormones on the skin.

The inhibitor DPP can promote hair growth.

Adenosine complex helps increase hair thickness and density in hair loss.

Schizophrenia risk genes may affect early brain development, contributing to the disease.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.